Wu Qingwen, deputy secretary of CPC Suzhou Municipal Committee and mayor of Suzhou, discussed further opening-up, innovation and cooperation via video link with Kent, senior executive for global operations at Roche Diagnostics and Harry de Wit, chief executive officer of Asia Pacific and president of Europe, Middle East and Africa at Fresenius Medical Care.
“As a time-honored city brimming with creativity and vitality, Suzhou remains one of the major magnets for international investment and regions that maintain sound momentum of development. In recent years, Suzhou has been committed to expanding high-level opening up, creating world-class business environment, and providing strong support for foreign companies to invest and develop in Suzhou,” said Wu Qingwen at the virtual meeting.
With optimal industrial chains, support from leading companies and prominent innovation results, biomedicine is hailed as the “No. 1 Industry” in Suzhou. The city is now striving to speed up innovation in policy and institution, integrated institutional innovation in industrial chain and remove impediments to the development of biomedicine industry and companies.
“Roche Group has every confidence in long-term development and investment in Suzhou. We hope to strengthen partnership and cooperation with Suzhou, and contribute to the creation of innovative products with high medical value,” said Kent.
“Our factory in Changshu is one of the most advanced industrial bases that Fresenius Group has built in recent years. We hope to have closer cooperation with Suzhou and our group will stand committed to Suzhou to achieve win-win results,” said Harry.
